Literature DB >> 9009328

Oral carriage of Candida albicans in murine AIDS.

N Deslauriers1, L Côté, S Montplaisir, L de Repentigny.   

Abstract

Oral candidiasis is a common fungal infection in patients infected with the human immunodeficiency virus (HIV). Although rare at the time of primary HIV infection, it is frequently found throughout the asymptomatic phase and is predictive of progressive immunodeficiency. However, the precise immune defect which results in outgrowth of commensal Candida albicans in HIV infection has not been identified. Mice infected with the Du5H(G6T2) mixture of mouse leukemia viruses develop a syndrome, designated murine AIDS (MAIDS), that has many of the immune abnormalities found in HIV infection. Retrovirus-infected C57BL/6 mice were examined for their ability to resist the development of oral candidiasis from the carrier state established after a self-limiting acute infection and to clear a subsequent secondary inoculum of oral C. albicans. Most of the mice orally colonized with C. albicans and then inoculated with the retrovirus mixture maintained a low-level oral carriage of C. albicans, while 30% of coinfected mice developed recurring 2- to 3-week episodes of acute Candida proliferation, separated by transient recoveries to the carrier state. The frequencies of CD4+ and CD8+ lymphocytes were, respectively, unchanged and significantly decreased (P < 0.05) in both cervical lymph nodes and spleens of coinfected mice compared to the corresponding frequencies in C. albicans-carrying, virus-free, age-matched control animals. Secretion of gamma interferon by concanavalin A (ConA)-stimulated spleen cells from Candida-carrying, retrovirus-infected mice was significantly decreased (P < 0.05) compared to that of C. albicans-carrying, retrovirus-free mice, in accordance with known abnormalities associated with MAIDS. However, production of this cytokine by ConA-stimulated or unstimulated cervical lymph node cells from coinfected mice was enhanced compared to that of virus-free animals colonized with C. albicans. Acquired resistance to reinfection with C. albicans was maintained in retrovirus-infected mice and was associated with a mucosal recruitment of CD8+ cells not observed in control mice. These results suggest that alterations in mucosal immunity which occur in MAIDS differ substantially from defects observed at other sites and that surrogate epithelial defense mechanisms may function locally to limit Candida proliferation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9009328      PMCID: PMC176111          DOI: 10.1128/iai.65.2.661-667.1997

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  44 in total

Review 1.  Regulation of immunity to parasites by T cells and T cell-derived cytokines.

Authors:  A Sher; R L Coffman
Journal:  Annu Rev Immunol       Date:  1992       Impact factor: 28.527

Review 2.  A TH1-->TH2 switch is a critical step in the etiology of HIV infection.

Authors:  M Clerici; G M Shearer
Journal:  Immunol Today       Date:  1993-03

3.  Dissemination of enteric Mycobacterium avium infections in mice rendered immunodeficient by thymectomy and CD4 depletion or by prior infection with murine AIDS retroviruses.

Authors:  I M Orme; S K Furney; A D Roberts
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

Review 4.  Multifactorial nature of human immunodeficiency virus disease: implications for therapy.

Authors:  A S Fauci
Journal:  Science       Date:  1993-11-12       Impact factor: 47.728

5.  Opportunistic infections and retrovirus-induced immunodeficiency: studies of acute and chronic infections with Toxoplasma gondii in mice infected with LP-BM5 murine leukemia viruses.

Authors:  R T Gazzinelli; J W Hartley; T N Fredrickson; S K Chattopadhyay; A Sher; H C Morse
Journal:  Infect Immun       Date:  1992-10       Impact factor: 3.441

6.  Retrovirus-induced immunodeficiency in mice exacerbates gastrointestinal candidiasis.

Authors:  G T Cole; K Saha; K R Seshan; K T Lynn; M Franco; P K Wong
Journal:  Infect Immun       Date:  1992-10       Impact factor: 3.441

7.  Resistance of SCID mice to Candida albicans administered intravenously or colonizing the gut: role of polymorphonuclear leukocytes and macrophages.

Authors:  J Jensen; T Warner; E Balish
Journal:  J Infect Dis       Date:  1993-04       Impact factor: 5.226

8.  High expression of NK-1.1 antigen is induced by infection with murine AIDS virus.

Authors:  M Makino; D F Winkler; J Wunderlich; J W Hartley; H C Morse; K L Holmes
Journal:  Immunology       Date:  1993-10       Impact factor: 7.397

9.  Mucosal and disseminated candidiasis in gnotobiotic SCID mice.

Authors:  E Balish; J Jensen; T Warner; J Brekke; B Leonard
Journal:  J Med Vet Mycol       Date:  1993

10.  CD4 T cells in murine acquired immunodeficiency syndrome: polyclonal progression to anergy.

Authors:  G Muralidhar; S Koch; M Haas; S L Swain
Journal:  J Exp Med       Date:  1992-06-01       Impact factor: 14.307

View more
  10 in total

1.  Cellular and cytokine correlates of mucosal protection in murine model of oral candidiasis.

Authors:  S Elahi; G Pang; R Clancy; R B Ashman
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

Review 2.  Candida-host interactions in HIV disease: implications for oropharyngeal candidiasis.

Authors:  P L Fidel
Journal:  Adv Dent Res       Date:  2011-04

Review 3.  Experimental oral candidiasis in animal models.

Authors:  Y H Samaranayake; L P Samaranayake
Journal:  Clin Microbiol Rev       Date:  2001-04       Impact factor: 26.132

4.  Characterization of CD8+ T cells and microenvironment in oral lesions of human immunodeficiency virus-infected persons with oropharyngeal candidiasis.

Authors:  Kelly M McNulty; Jananya Plianrungsi; Janet E Leigh; Donald Mercante; Paul L Fidel
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

5.  Proteolytic activation of the interleukin-1beta precursor by Candida albicans.

Authors:  A Beauséjour; D Grenier; J P Goulet; N Deslauriers
Journal:  Infect Immun       Date:  1998-02       Impact factor: 3.441

Review 6.  Oropharyngeal candidiasis in the era of antiretroviral therapy.

Authors:  George R Thompson; Payal K Patel; William R Kirkpatrick; Steven D Westbrook; Deborah Berg; Josh Erlandsen; Spencer W Redding; Thomas F Patterson
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2010-02-13

7.  A novel immunocompetent murine model for Candida albicans-promoted oral epithelial dysplasia.

Authors:  P P Dwivedi; S Mallya; A Dongari-Bagtzoglou
Journal:  Med Mycol       Date:  2008-06-10       Impact factor: 4.076

8.  Combination of Estrogen and Immunosuppressive Agents to Establish a Mouse Model of Candidiasis with Concurrent Oral and Vaginal Mucosal Infection.

Authors:  Le Wang; Chong Wang; Huan Mei; Yongnian Shen; Guixia Lv; Rong Zeng; Ping Zhan; Dongmei Li; Weida Liu
Journal:  Mycopathologia       Date:  2015-09-24       Impact factor: 2.574

9.  CD8+ T cells but not polymorphonuclear leukocytes are required to limit chronic oral carriage of Candida albicans in transgenic mice expressing human immunodeficiency virus type 1.

Authors:  Miriam Marquis; Daniel Lewandowski; Véronique Dugas; Francine Aumont; Serge Sénéchal; Paul Jolicoeur; Zaher Hanna; Louis de Repentigny
Journal:  Infect Immun       Date:  2006-04       Impact factor: 3.441

10.  Sequential Dysfunction and Progressive Depletion of Candida albicans-Specific CD4 T Cell Response in HIV-1 Infection.

Authors:  Fengliang Liu; Xiuzhen Fan; Sarah Auclair; Monique Ferguson; Jiaren Sun; Lynn Soong; Wei Hou; Robert R Redfield; Deborah L Birx; Silvia Ratto-Kim; Merlin L Robb; Jerome H Kim; Nelson L Michael; Haitao Hu
Journal:  PLoS Pathog       Date:  2016-06-09       Impact factor: 6.823

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.